Efficacy of Different Anti-Thrombotic Strategies on the Incidence of Silent Cerebral Embolism After Percutaneous Left Atrial Appendage Occlusion

NCT05671276 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation
Left Atrial Appendage Occlusion
Silent Cerebral Embolism

Interventions

DRUG: aspirin and clopidogrel
DRUG: Rivaroxaban

Sponsor

The First Affiliated Hospital with Nanjing Medical University

Collaborators

[object Object]
[object Object]